Shares

Information on Sartorius preference shares (SRT3) and Sartorius ordinary shares (SRT) at a glance

Stock Chart

Financial Calendar

Learn More

Overview

ISINOrdinary share: DE0007165607 | Preference share: DE0007165631 
SE CodeOrdinary share: SRT | Preference share: SRT3 
Market SegmentPrime Standard 
IndicesMDAX | TecDAX | MSCI Germany Index | CDAX | Prime All-Share-Index | Technology All Share-Index | NISAX20 | STOXX Europe 600
Market placesXETRA | Frankfurt Main | Hanover | Hamburg | Berlin | Munich | Düsseldorf | Stuttgart
Designated SponsorsOddo Seydler Bank AG | M.M. Warburg & Co.
First trading dayJuly, 10, 1990; Issue price: Ordinary share DM 710 | 
Preference share DM 610
Capital stock74,880,000 euros
Number of shares74,880,000 no-par individual share certificates; 
thereof ordinary shares: 37,440,000 | preference shares: 37,440,000
Number of shares outstandingOrdinary shares: 34,212,224 | Preference shares: 34,176,068
Post IPO Activities

04.06.1998:
Capital increase by DM 11 million to DM 36 million by preference share at the issue price of DM 630

13.12.1999:
Conversion of DM 50 par value shares to individual share certificate with an accounting par value of 1 euro at a ratio of 1:26 (stock split)

13.06.2016:

Capital increase by use of retained earnings for carrying out a stock split at a ratio of 1:4

Sartorius AG is currently covered by 17 sell-side analysts. The following list shows their latest recommendations for Sartorius preference shares.


InstitutionAnalystDateTarget PriceRecommendation

UBS

Michael Leuchten

20.02.19

147.00

Hold

Commerzbank

Daniel Wendorff31.01.19133.00Hold
Kepler CheuvreuxOliver Reinberg30.01.19107.00Sell
M.M. WarburgMichael Heider30.01.19145.00Buy
MetzlerAlexander Neuberger30.01.19128.00Hold
JanneyPaul Knight30.01.19140.00Hold
MainfirstMarkus Gola29.01.19140.00Buy
BerenbergScott Bardo29.01.19110.00Hold
AlphaValueKamla Singh24.10.18118.00Sell
DZ BankSven Kürten24.10.1892.00Sell
Hauck & AufhäuserAliaksandr Halitsa24.10.18105.00Hold
LBBWVolker Stoll24.10.18120.00Hold
Deutsche BankGunnar Romer23.10.18115.00Hold
HSBCRichard Latz18.10.1899.00Sell
EQUI.TSThomas J. Schießle26.07.18125.00Hold
Nord LBVolker Sack26.07.1880.00Sell
Oddo SeydlerIgor Kim 24.07.18109.00Sell

Disclaimer

The analysts’ estimates listed above as examples are not based on research or analyses conducted by Sartorius AG, but rather exclusively on analyses, research, reports, recommendations or ratings of third parties. References to such recommendations and ratings are provided as convenience for readers and for non-binding informational purposes only. These references do not imply that Sartorius AG adopts, endorses or confirms in any way the recommendations, options, opinions, conclusions or estimates of analysts. In particular, analysts’ estimates do not constitute any investment advice given by Sartorius AG. None of the information provided is intended as an offer or encouragement to buy Sartorius shares or other financial instruments, nor is it an offer to purchase or sell.

Sartorius AG shall not assume any liability, in particular for the selection, topicality, quality, completeness or accuracy of the analysts’ estimates shown and, if any, of analysts’ recommendations. Any liability on the part of Sartorius AG for damages or losses incurred by third parties based on the information published on this website shall be excluded.

Ordinary sharesPreference shares
Administered by an executor~50%Free float~91%
Bio-Rad Laboratories Inc.~34%Treasury shares~9%
Treasury shares~9%  
Members of the familiy~5%  
Free float~2%  


Information on shareholdings and shares in free float pursuant to Sections 33 et seq. of the German Securities Trading Act (WpHG). Reporting obligations refer only to voting shares and not to non-voting preference shares. For this reason, the shareholder structure disclosed for Sartorius preference shares does not contain any detailed information beyond the company’s treasury shares.

More Information

Investor Relations Sartorius AG

Learn More

About Sartorius

Learn More

Sartorius Stedim Biotech Share

Learn More